TGFB1 and pulmonary fibrosis: Studies have shown that indole alkaloids can moderate the TGF-β signaling pathway and exhibit excellent anti-pulmonary fibrosis activity, making them as potential lead drugs for the treatment of pulmonary fibrosis [19].